The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

This study has been completed.
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
Aventis Pharmaceuticals
GlaxoSmithKline
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Gerstein, Hertzel, MD
ClinicalTrials.gov Identifier:
NCT00095654
First received: November 5, 2004
Last updated: November 9, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):